Sequoia Sciences announced yesterday that it has received fast-track designation from the US Food and Drug Administration (FDA) for its investigational vaccine designed to treat recurrent urinary tract infections (UTIs) caused by multidrug-resistant (MDR) bacteria. Fast-track designation expedites the development and review of the vaccine through the US regulatory process.
A study today in Genome Biology suggests methicillin-resistant Staphylococcus aureus (MRSA) emerged several years before methicillin was used to treat S aureus infections.
Researchers in New Zealand report today in The Lancet that exposure to the outer-membrane vesical meningococcal B vaccine (MeNZB) was associated with reduced rates of gonorrhea in a retrospective case-control study. It's the first time a vaccine has shown any protection against the sexually transmitted infection.
New data raise the specter of completely resistant Neisseria gonorrhoeae strains, and options are few.
A surveillance study yesterday in BMC Infectious Diseases reports high levels of resistance to previously recommended antimicrobials in Neisseria gonorrhea isolates from a city in eastern China.
An analysis of Neisseria gonorrhea isolates from a sexually transmitted infection (STI) clinic in Amsterdam shows a rise in decreased susceptibility to azithromycin and ceftriaxone, researchers report today in Eurosurveillance.
Syphilis cases jumped 19%, gonorrhea increased by 12.8%, and chlamydia by 5.9% from 2014.
A cluster in Hawaii involves bacteria with high resistance to azithromycin and reduced susceptibility to ceftriaxone.
Data from 2014 showed that resistance to the antibiotic azithromycin quadrupled from 2013.
